EMA (European Medicines Agency). 2010. The European Medicines Agency Road Map to 2015: The Agency’s Contribution to Science, Medicines, Health, Draft for Public Consultation. London: EMA.
FDA (Food and Drug Administration). 2010. Advancing Regulatory Science for Public Health. http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm228131.htm (accessed November 28, 2011).
FDA. 2011. Advancing Regulatory Science at FDA: A Strategic Plan. http://www.fda.gov/regulatoryscience (accessed November 28, 2011).
FDA Science Board. 2007. FDA Science and Mission at Risk. Rockville, MD: Report of the Subcommittee on Science and Technology.
Hirsch, G. 2011. NEWDIGS: New Drug Development ParadIGmS: Applying MIT systems expertise to transform healthcare innovation. Presentation at IOM workshop on Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development, September 21, Washington, DC.
IOM (Institute of Medicine). 2011. Building a National Framework for the Establishment of Regulatory Science for Drug Development: Workshop Summary. Washington, DC: The National Academies Press.
Mollet, A. 2011. Education and Training of a Regulatory Science Workforce—European Initiatives. Presentation at IOM workshop on Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development, September 20, Washington, DC.
Seyfert-Margolis, V. 2011. Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: An Institute of Medicine Workshop. Speaker presentation at IOM workshop on Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development, September 20, Washington, DC.
Ukwu, H. 2011. Regulatory Science in Therapeutics Development. Presentation at IOM workshop on Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development, September 20, Washington, DC.
